These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 18925527)

  • 21. Maternal serum ADMA is not associated with proinflammatory cytokines or C-reactive protein during normal pregnancy.
    Valtonen P; Punnonen K; Saarelainen H; Heiskanen N; Raitakari OT; Viikari JS; Lyyra-Laitinen T; Laitinen T; Heinonen S
    Cytokine; 2009 May; 46(2):216-21. PubMed ID: 19268605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased asymmetric dimethylarginine serum levels are associated with acute rejection in kidney transplant recipients.
    Esposito C; Grosjean F; Torreggiani M; Maggi N; Esposito V; Migotto C; Mangione F; Tinelli C; Dal Canton A
    Transplant Proc; 2009 Jun; 41(5):1570-3. PubMed ID: 19545681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relation of asymmetrical dimethylarginine levels with renal outcomes in hypertensive patients with and without type 2 diabetes mellitus.
    Triches CB; Quinto M; Mayer S; Batista M; Zanella MT
    J Diabetes Complications; 2018 Mar; 32(3):316-320. PubMed ID: 29398328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Level of asymmetric dimethylarginine and carotid atherosclerosis in patients with chronic kidney disease.
    Zhang WR; Hou FF; Ning JP; Yang XB; Wu Q; Tao LJ; Chen BM; Li HY; Chang L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 31(5):621-8. PubMed ID: 17062918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased circulating concentrations of asymmetric dimethylarginine (ADMA) in white coat hypertension.
    Curgunlu A; Uzun H; Bavunoğlu I; Karter Y; Genç H; Vehid S
    J Hum Hypertens; 2005 Aug; 19(8):629-33. PubMed ID: 15829997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship of asymmetric dimethylarginine with flow-mediated dilatation in subjects with newly detected severe hypercholesterolemia.
    Vladimirova-Kitova L; Deneva T; Angelova E; Nikolov F; Marinov B; Mateva N
    Clin Physiol Funct Imaging; 2008 Nov; 28(6):417-25. PubMed ID: 18798847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Asymmetric dimethylarginine serum concentration in normal weight and obese CKD patients treated with hemodialysis.
    Alipoor E; Salehi S; Dehghani S; Yaseri M; Hosseinzadeh-Attar MJ
    BMC Nephrol; 2024 Sep; 25(1):294. PubMed ID: 39237885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study.
    Schnabel R; Blankenberg S; Lubos E; Lackner KJ; Rupprecht HJ; Espinola-Klein C; Jachmann N; Post F; Peetz D; Bickel C; Cambien F; Tiret L; Münzel T
    Circ Res; 2005 Sep; 97(5):e53-9. PubMed ID: 16100045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma asymmetric dimethylarginine concentrations in newly diagnosed patients with acute myocardial infarction or unstable angina pectoris during two weeks of medical treatment.
    Bae SW; Stühlinger MC; Yoo HS; Yu KH; Park HK; Choi BY; Lee YS; Pachinger O; Choi YH; Lee SH; Park JE
    Am J Cardiol; 2005 Mar; 95(6):729-33. PubMed ID: 15757598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Asymmetric dimethylarginine, cortisol/cortisone ratio, and C-peptide: markers for diabetes and cardiovascular risk?
    Anderson JL; Carlquist JF; Roberts WL; Horne BD; May HT; Schwarz EL; Pasquali M; Nielson R; Kushnir MM; Rockwood AL; Bair TL; Muhlestein JB;
    Am Heart J; 2007 Jan; 153(1):67-73. PubMed ID: 17174641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uncomplicated type 1 diabetes is associated with increased asymmetric dimethylarginine concentrations.
    Altinova AE; Arslan M; Sepici-Dincel A; Akturk M; Altan N; Toruner FB
    J Clin Endocrinol Metab; 2007 May; 92(5):1881-5. PubMed ID: 17311854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Putative role of asymmetric dimethylarginine in microvascular disease of kidney and heart in hypertensive patients.
    Fujii H; Takiuchi S; Kawano Y; Fukagawa M
    Am J Hypertens; 2008 Jun; 21(6):650-6. PubMed ID: 18443575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gender differences in the relationships between chronic kidney disease, asymmetric dimethylarginine, and sleep quality: The HEIJO-KYO cohort.
    Obayashi K; Kurumatani N; Saeki K
    Nitric Oxide; 2018 Sep; 79():25-30. PubMed ID: 29983400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Asymmetric dimethylarginine determines the improvement of endothelium-dependent vasodilation by simvastatin: Effect of combination with oral L-arginine.
    Böger GI; Rudolph TK; Maas R; Schwedhelm E; Dumbadze E; Bierend A; Benndorf RA; Böger RH
    J Am Coll Cardiol; 2007 Jun; 49(23):2274-82. PubMed ID: 17560293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of multi-channel auditory steady-state response in adults with sensorineural hearing loss.
    Lin YH; Chen PR; Hsu CJ; Wu HP
    J Laryngol Otol; 2009 Jan; 123(1):38-44. PubMed ID: 18452631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ADMA, proteinuria, and insulin resistance in non-diabetic stage I chronic kidney disease.
    Caglar K; Yilmaz MI; Sonmez A; Cakir E; Kaya A; Acikel C; Eyileten T; Yenicesu M; Oguz Y; Bilgi C; Oktenli C; Vural A; Zoccali C
    Kidney Int; 2006 Aug; 70(4):781-7. PubMed ID: 16820789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Asymmetric dimethylarginine concentrations decrease in patients with HIV infection under antiretroviral therapy.
    Kurz K; Teerlink T; Sarcletti M; Weiss G; Zangerle R; Fuchs D
    Antivir Ther; 2012; 17(6):1021-7. PubMed ID: 22892398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improving proteinuria, endothelial functions and asymmetric dimethylarginine levels in chronic kidney disease: ramipril versus valsartan.
    Yilmaz MI; Saglam M; Sonmez A; Caglar K; Cakir E; Kurt Y; Eyileten T; Tasar M; Acikel C; Oguz Y; Vural A; Yenicesu M
    Blood Purif; 2007; 25(4):327-35. PubMed ID: 17709915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Asymmetric dimethylarginine as a useful risk marker of radial artery calcification in patients with advanced kidney disease.
    Krzanowski M; Krzanowska K; Gajda M; Dumnicka P; Kopeć G; Guzik B; Woziwodzka K; Dziewierz A; Litwin JA; Sułowicz W
    Pol Arch Intern Med; 2018 Mar; 128(3):157-165. PubMed ID: 29600966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of breastfeeding on serum asymmetric dimethylarginine levels and body composition in children.
    Roszkowska R; Taranta-Janusz K; Tenderenda-Banasiuk E; Wasilewska A
    Breastfeed Med; 2015; 10(1):38-44. PubMed ID: 25358091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.